Diabetic Macular Edema (DME) Unknown Status Phase 1 / 2 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Unknown Status1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03973138Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With RanibizumabTreatment
NCT01845844Ranibizumab For Persistent Diabetic Macular Edema After BevacizumabTreatment